Answer
Isoniazid inhibits carbamazepine metabolism and, at isoniazid doses of 200 mg daily or more, has caused substantial increases in carbamazepine concentrations and toxicity; concurrent use is not recommended unless effects can be closely monitored and suitable downward dosage adjustments made.
Sources for this answer
- Isoniazid Tablets BP 50mgRPH Pharmaceuticals AB · emc · SmPC §4.5 Interaction with other medicinal products · Version 6Document updated
Sources checked